Published in Vaccine Weekly, February 21st, 2001
"Widespread use of meningococcal A and C polysaccharide (MACP) vaccines has raised concerns about induction of hyporesponsiveness to these polysaccharides," wrote R. Borrow and colleagues, Withington Hospital, in the journal Vaccine. "Immunological hyporesponsiveness to C polysaccharide has been clearly documented in infants, children, and adults but only limited data from Gambian children are available for A polysaccharide."
"We investigated whether a second...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-02-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.